TPM2 and colorectal carcinoma: The expression levels of TPM2, RPS17, and TNNT1 progressively increased during the progression and metastasis of colorectal cancer (CRC); in contrast, SPINK4 expression initially rose before sharply declining (Figures 5B, C).